Radiation Therapy With or Without Cisplatin in Treating Patients With Stage I, Stage II, or Stage III Cancer of the Vulva
A Randomized Study of Adjuvant Radiation Treatment Versus Radiation and Chemotherapy in Patients With Vulvar Cancer and Involved Nodes
Sponsor: Gynecologic Oncology Group
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from Gynecologic Oncology Group
- Ovarian Neoplasms · Phase PHASE2 · Jan 2022
- Stage I Uterine Sarcoma AJCC v7 · Phase PHASE3 · Feb 2019
- Cervical Adenocarcinoma · Phase NA · Jan 2013
- Cervical Adenocarcinoma · Phase PHASE3 · Aug 2010
- Lymphedema · Phase PHASE3 · Jul 2009
More terminations from Gynecologic Oncology Group
Other Vulvar Cancer trials with similar outcome
This PHASE3 trial investigates Vulvar Cancer and is currently terminated or withdrawn. Gynecologic Oncology Group leads this study, which shows 7 recorded versions since 2001 — indicating limited longitudinal coverage. As an oncology study, it adds to the longitudinal record of treatment development for this indication.
Status Flow
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Feb 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Feb 2021 [monthly]
Terminated PHASE3
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE3
First recorded
Mar 2001
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Gynecologic Oncology Group
- National Cancer Institute (NCI)
For direct contact, visit the study record on ClinicalTrials.gov .